Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-26 @ 11:13 AM
Ignite Modification Date:
2025-12-26 @ 11:13 AM
NCT ID:
NCT00667628
Pre Assignment Details:
Randomization was balanced between treatment arms according to the stratification factors of number of lesions (less than \[\<\] 5 versus greater than equal to \[\>=\] 5) and baseline alpha-fetoprotein (AFP) level (\<400 nanograms per milliliters \[ng/mL\] versus \>=400 ng/mL).
Recruitment Details:
A total of 67 participants were screened, of which 54 participants received the first transcatheter arterial chemoembolization (TACE) prior to randomization. Two participants discontinued prior to randomization due to adverse event and thus, a total of 52 participants were randomized in the study and received study drug in the double-blind period. The study was prematurely terminated by the Sponsor due to safety concerns.
Study:
NCT00667628
Study Brief:
Results Section:
NCT00667628